ArticleInternational journal of clinical and experimental medicine2014
Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma.
Article in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
- CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability.Cancers · 2025Review
- Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration.Cancers · 2022Article
- High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma.Oncology letters · 2018Article
- Met inactivation by S-allylcysteine suppresses the migration and invasion of nasopharyngeal cancer cells induced by hepatocyte growth factor.Radiation oncology journal · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocyte growth factor (HGF) and its receptor, c-Met, are associated with invasive tumor growth. This study sought to profile the expression of HGF and c-Met in nasopharyngeal carcinoma (NPC) tissue. Of 221 patients recruited between March 2010 and September 2013, 106 were diagnosed with nasopharyngeal carcinoma; the remaining 115 had nasal inflammation (nasopharyngeal mucositis) and were used as controls. Inmmunohistochemistry was used to detect the expression of HGF and c-Met in tissue samples. HGF and c-Met were predominantly expressed in the columnar nasopharyngeal epithelium. The proportion of samples expressing HGF and c-Met was significantly higher in NPC than in controls (P < 0.001). Further, the proportion of samples expressing c-Met and HGF (P < 0.01, P < 0.05, respectively) was significantly higher in NPC stages III and IV than in stages I and II. The expression of c-Met was also significantly correlated with cervical lymph node metastasis. Thus, HGF and c-Met expression are upregulated in nasopharyngeal carcinoma. That their expression correlates with disease severity and metastasis may indicate that these proteins promote tumor invasion. Further research could determine the utility of c-Met as a biomarker for the prognosis of NPC.
Indexed as
Identifiers
25664076PMC4307523W26072125What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.